Immatics beruft Biot
Immatics beruft Biotech-Experten Eliot Forster in den Aufsichtsrat
September 15, 2020 07:00 ET | Immatics N.V.
Tübingen, Deutschland und Houston, Texas, 15. September 2020 – Immatics N.V. (NASDAQ: IMTX; „Immatics“), ein Unternehmen, das sich auf die Entwicklung und Herstellung von T-Zell-Immuntherapien für die...
Immatics veröffentli
Immatics veröffentlicht Update zu ACTengine®-Zelltherapieprogramm IMA204 gegen eine Tumor-Stroma-Zielstruktur
September 10, 2020 07:00 ET | Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Das ACTengine®-Zelltherapieprogramm IMA204 adressiert COL6A3 Exon 6, eine neuartige Zielstruktur, die im...
Immatics Provides Up
Immatics Provides Update on IMA204 ACTengine® Cell Therapy Program Targeting the Tumor Microenvironment
September 10, 2020 07:00 ET | https://immatics.com/
Tuebingen, Germany and Houston, Texas, Sept. 10, 2020 (GLOBE NEWSWIRE) -- IMA204 ACTengine® cell therapy program directed at novel tumor target COL6A3 exon 6 prevalently expressed at high copy...
AlloVir_Logo_FullColor[2].png
AlloVir Appoints Ercem Atillasoy, M.D., as Chief Regulatory and Safety Officer
September 08, 2020 16:15 ET | AlloVir Inc.
CAMBRIDGE, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- AlloVir (Nasdaq: ALVR), a late clinical-stage cell therapy company, announced the appointment of Ercem Atillasoy, M.D., as the company’s Chief...
22157.jpg
Worldwide Cell Therapy Industry to 2025 - North America is Leading the Cell Therapy Market
September 07, 2020 05:38 ET | Research and Markets
Dublin, Sept. 07, 2020 (GLOBE NEWSWIRE) -- The "Cell Therapy Market- Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering. The cell therapy market...
Immatics veröffentli
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2020 sowie Informationen zur Geschäftsentwicklung
September 03, 2020 07:00 ET | Immatics N.V.
Tübingen, Deutschland und Houston, Texas, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Abschluss der Fusion mit ARYA Life Science Acquisition Corp. sowie anschließende Börsennotierung an der NASDAQ im...
Immatics Announces S
Immatics Announces Second Quarter 2020 Financial Results and Business Update
September 03, 2020 07:00 ET | https://immatics.com/
Tuebingen, Germany and Houston, TX, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Completed merger with ARYA Life Science Acquisition Corp. and subsequent NASDAQ listing with proceeds from the transaction...
22157.jpg
Viral Vector Manufacturing Industry by Type, Application, End-user and Region - Forecast to 2025
August 31, 2020 07:04 ET | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Viral Vector Manufacturing Market - Forecasts from 2020 to 2025" report has been added to ResearchAndMarkets.com's offering. The global viral vector...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020
August 26, 2020 07:00 ET | BioCardia, Inc.
SAN CARLOS, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies today...
AlloVir_Logo_FullColor[2].png
AlloVir to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
August 25, 2020 07:30 ET | AlloVir Inc.
CAMBRIDGE, Mass., Aug. 25, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, will present a corporate overview at the virtual Morgan Stanley 18th...